Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.
The Parallel-R1 framework uses reinforcement learning to teach models how to explore multiple reasoning paths at once, ...
Moxonidine is prescribed for the treatment of hypertension and the approval strengthens Relonchem’s growing product presence ...
United Therapeutics Corporation ( NASDAQ: UTHR) Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 1:10 PM EDT ...
The USC Trojans became very pass happy in their first season in the Big Ten conference a year ago. This season, Lincoln Riley ...
The IPO is aimed at strengthening Atlanta Electricals’ manufacturing base and providing liquidity to its promoter ...